Go Pro

PACS Group (PACS) Competitors

PACS Group logo
$42.41 +0.35 (+0.82%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$42.40 0.00 (-0.01%)
As of 09/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PACS vs. THC, EHC, UHS, ENSG, and CON

Should you buy PACS Group stock or one of its competitors? PACS Group's main competitors and comparable companies include Tenet Healthcare (THC), Encompass Health (EHC), Universal Health Services (UHS), The Ensign Group (ENSG), and Concentra Group Holdings Parent (CON). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare facilities" industry.

How does PACS Group compare to Tenet Healthcare?

Tenet Healthcare (NYSE:THC) and PACS Group (NYSE:PACS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Tenet Healthcare has higher revenue and earnings than PACS Group. Tenet Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenet Healthcare$21.31B0.99$1.41B$25.9310.08
PACS Group$5.29B1.27$191.54M$1.7224.65

In the previous week, PACS Group had 9 more articles in the media than Tenet Healthcare. MarketBeat recorded 22 mentions for PACS Group and 13 mentions for Tenet Healthcare. Tenet Healthcare's average media sentiment score of 0.65 beat PACS Group's score of 0.41 indicating that Tenet Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenet Healthcare
5 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tenet Healthcare currently has a consensus target price of $277.89, suggesting a potential upside of 6.29%. PACS Group has a consensus target price of $58.80, suggesting a potential upside of 38.66%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than Tenet Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenet Healthcare
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

95.4% of Tenet Healthcare shares are owned by institutional investors. 1.0% of Tenet Healthcare shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Tenet Healthcare has a net margin of 10.27% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Tenet Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenet Healthcare10.27% 26.76% 5.55%
PACS Group 4.85%29.55%5.23%

Tenet Healthcare has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

Summary

Tenet Healthcare beats PACS Group on 11 of the 17 factors compared between the two stocks.

How does PACS Group compare to Encompass Health?

PACS Group (NYSE:PACS) and Encompass Health (NYSE:EHC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

97.3% of Encompass Health shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 1.8% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, PACS Group had 13 more articles in the media than Encompass Health. MarketBeat recorded 22 mentions for PACS Group and 9 mentions for Encompass Health. Encompass Health's average media sentiment score of 0.91 beat PACS Group's score of 0.41 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Encompass Health
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Encompass Health has a net margin of 10.01% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Encompass Health's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.85% 29.55% 5.23%
Encompass Health 10.01%18.08%8.22%

PACS Group has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market. Comparatively, Encompass Health has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market.

Encompass Health has higher revenue and earnings than PACS Group. Encompass Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.27$191.54M$1.7224.65
Encompass Health$5.94B2.03$566.20M$6.1419.84

PACS Group presently has a consensus target price of $58.80, suggesting a potential upside of 38.66%. Encompass Health has a consensus target price of $148.20, suggesting a potential upside of 21.63%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Encompass Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Encompass Health
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

Encompass Health beats PACS Group on 11 of the 16 factors compared between the two stocks.

How does PACS Group compare to Universal Health Services?

PACS Group (NYSE:PACS) and Universal Health Services (NYSE:UHS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

86.1% of Universal Health Services shares are held by institutional investors. 70.1% of PACS Group shares are held by company insiders. Comparatively, 17.1% of Universal Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Universal Health Services has higher revenue and earnings than PACS Group. Universal Health Services is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.27$191.54M$1.7224.65
Universal Health Services$17.36B0.60$1.49B$24.557.20

In the previous week, PACS Group had 12 more articles in the media than Universal Health Services. MarketBeat recorded 22 mentions for PACS Group and 10 mentions for Universal Health Services. Universal Health Services' average media sentiment score of 0.90 beat PACS Group's score of 0.41 indicating that Universal Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Universal Health Services
4 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market. Comparatively, Universal Health Services has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Universal Health Services has a net margin of 8.42% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Universal Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.85% 29.55% 5.23%
Universal Health Services 8.42%19.39%9.21%

PACS Group presently has a consensus target price of $58.80, suggesting a potential upside of 38.66%. Universal Health Services has a consensus target price of $204.94, suggesting a potential upside of 15.96%. Given PACS Group's stronger consensus rating and higher probable upside, research analysts plainly believe PACS Group is more favorable than Universal Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Universal Health Services
0 Sell rating(s)
12 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Universal Health Services beats PACS Group on 9 of the 16 factors compared between the two stocks.

How does PACS Group compare to The Ensign Group?

PACS Group (NYSE:PACS) and The Ensign Group (NASDAQ:ENSG) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

The Ensign Group has lower revenue, but higher earnings than PACS Group. PACS Group is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.27$191.54M$1.7224.65
The Ensign Group$5.06B2.00$343.97M$6.3827.26

PACS Group has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market. Comparatively, The Ensign Group has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market.

96.1% of The Ensign Group shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 4.0% of The Ensign Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, PACS Group had 11 more articles in the media than The Ensign Group. MarketBeat recorded 22 mentions for PACS Group and 11 mentions for The Ensign Group. The Ensign Group's average media sentiment score of 0.56 beat PACS Group's score of 0.41 indicating that The Ensign Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
The Ensign Group
2 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

The Ensign Group has a net margin of 6.90% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat The Ensign Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.85% 29.55% 5.23%
The Ensign Group 6.90%16.75%6.97%

PACS Group presently has a consensus target price of $58.80, indicating a potential upside of 38.66%. The Ensign Group has a consensus target price of $216.25, indicating a potential upside of 24.35%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than The Ensign Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
The Ensign Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

The Ensign Group beats PACS Group on 9 of the 16 factors compared between the two stocks.

How does PACS Group compare to Concentra Group Holdings Parent?

Concentra Group Holdings Parent (NYSE:CON) and PACS Group (NYSE:PACS) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, PACS Group had 17 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 22 mentions for PACS Group and 5 mentions for Concentra Group Holdings Parent. Concentra Group Holdings Parent's average media sentiment score of 0.86 beat PACS Group's score of 0.41 indicating that Concentra Group Holdings Parent is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concentra Group Holdings Parent
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Concentra Group Holdings Parent presently has a consensus price target of $39.40, suggesting a potential upside of 11.22%. PACS Group has a consensus price target of $58.80, suggesting a potential upside of 38.66%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentra Group Holdings Parent
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Concentra Group Holdings Parent has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market.

Concentra Group Holdings Parent has a net margin of 8.69% compared to PACS Group's net margin of 4.85%. Concentra Group Holdings Parent's return on equity of 47.81% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentra Group Holdings Parent8.69% 47.81% 7.04%
PACS Group 4.85%29.55%5.23%

PACS Group has higher revenue and earnings than Concentra Group Holdings Parent. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentra Group Holdings Parent$2.16B2.09$166.41M$1.5522.85
PACS Group$5.29B1.27$191.54M$1.7224.65

Summary

Concentra Group Holdings Parent beats PACS Group on 9 of the 15 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PACS vs. The Competition

MetricPACS GroupHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$6.67B$9.75B$7.24B$23.10B
Dividend YieldN/A2.62%2.57%3.62%
P/E Ratio24.6534.09275.4928.21
Price / Sales1.274.98646.0120.34
Price / Cash26.35121.7676.2536.36
Price / Book6.975.3010.464.67
Net Income$191.54M$313.45M$3.49B$1.07B
7 Day Performance-5.14%1.65%0.59%-1.64%
1 Month Performance-3.18%-0.85%-1.74%-3.60%
1 Year Performance253.09%16.30%18.13%8.41%

PACS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PACS
PACS Group
4.6588 of 5 stars
$42.41
+0.8%
$58.80
+38.7%
+253.1%$6.67B$5.29B24.6547,455
THC
Tenet Healthcare
3.7652 of 5 stars
$260.90
-1.4%
$275.53
+5.6%
+37.5%$21.01B$22.64B10.0699,000
EHC
Encompass Health
4.8073 of 5 stars
$122.07
-0.4%
$146.83
+20.3%
-1.7%$12.04B$6.21B19.8842,000
UHS
Universal Health Services
3.4822 of 5 stars
$176.32
+1.8%
$204.93
+16.2%
-6.3%$10.39B$18.11B7.18101,500
ENSG
The Ensign Group
4.5051 of 5 stars
$173.02
-1.1%
$216.25
+25.0%
+5.9%$10.09B$5.49B27.1346,000

Related Companies and Tools


This page (NYSE:PACS) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners